Latest news with #SeriesAShares
National Post
07-08-2025
- Business
- National Post
Emera Incorporated Announces Results of Series A and Series B First Preferred Shares Conversion
Article content HALIFAX, Nova Scotia — Emera Incorporated ('Emera' or the 'Company') (TSX/NYSE: EMA) announces that it has provided notice to the holders of its Cumulative 5-Year Rate Reset First Preferred Shares, Series A (the 'Series A Shares') and to the holders of its Cumulative Floating Rate First Preferred Shares, Series B (the 'Series B Shares') that 1,300 of its 4,866,814 issued and outstanding Series A Shares were tendered for conversion, on a one-for-one basis, into Series B Shares and that 569,430 of its 1,133,186 issued and outstanding Series B Shares were tendered for conversion, on a one-of-one basis, into Series A Shares. Article content Emera has also notified holders of its Series A Shares and Series B Shares, after having taken into account all shares tendered for conversion by holders of its Series A Shares and Series B Shares, as the case may be (collectively, the 'Holders'), by the July 31, 2025 deadline for conversion notices, the Company has determined that there would be outstanding on August 15, 2025 (the 'Conversion Date') less than 1,000,000 Series B Shares. Therefore, in accordance with certain conditions set out in the Company's prospectus supplement dated May 26, 2010, to the Company's short form base shelf prospectus dated May 19, 2010 (collectively, the 'Prospectus'), the Company has advised the Holders that no Series A Shares will be converted into Series B Shares and all remaining Series B Shares will automatically be converted into Series A Shares on a one-for-one basis on the Conversion Date. Article content Article content Emera further announces that it will have 6,000,000 Series A Shares issued and outstanding after conversion on August 15, 2025. The Series A Shares will continue to be listed on the Toronto Stock Exchange ('TSX') under the symbol The Series B Shares will no longer be listed on the TSX after the Conversion Date. Article content Holders of Series A Shares will have the opportunity to convert their shares again on August 15, 2030, and every five years thereafter as long as the shares remain outstanding. For more information on the terms of, and risks associated with, an investment in Series A Shares and Series B Shares, please see the Company's Prospectus, which is available on SEDAR+ at Article content Forward Looking Information Article content This news release contains forward-looking information or forward looking statements within the meaning of applicable securities laws (collectively, 'forward-looking information'), including without limitation, statements about Series A Shares and Series B Shares. By its nature, forward-looking information requires Emera to make assumptions and is subject to inherent risks and uncertainties. These statements reflect Emera management's current beliefs and are based on information currently available to Emera management. There is a risk that predictions, forecasts, conclusions and projections that constitute forward-looking information will not prove to be accurate, that Emera's assumptions may not be correct and that actual results may differ materially from those expressed or implied by such forward-looking information. The forward-looking information in this news release is made only as of the date of thereof, and Emera disclaims any intention or obligation to update or revise any such forward-looking information. Additional detailed information about these assumptions, risks and uncertainties is included in Emera's securities regulatory filings, including under the heading 'Enterprise Risk and Risk Management' in Emera's annual Management's Discussion and Analysis, and under the heading 'Principal Financial Risks and Uncertainties' in the notes to Emera's annual and interim financial statements, which can be found on SEDAR+ at or on EDGAR at Article content About Emera Article content Emera (TSX/NYSE: EMA) is a leading North American provider of energy services headquartered in Halifax, Nova Scotia, with investments in regulated electric and natural gas utilities, and related businesses and assets. The Emera family of companies delivers safe, reliable energy to approximately 2.6 million customers in Canada, the United States and the Caribbean. Our team of 7,600 employees is committed to our purpose of energizing modern life and delivering a cleaner energy future for all. Emera's common and preferred shares are listed and trade on the Toronto Stock Exchange and its common shares are listed and trade on the New York Stock Exchange. Additional information can be accessed at on SEDAR+ at and on EDGAR at Article content Article content Article content Contacts Article content Emera Inc. Article content Article content Investor Relations Article content 902-233-2674 Article content Article content Article content Article content
Associated Press
07-05-2025
- Business
- Associated Press
Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment
ONTARIO, Calif., May 7, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ('Nature's Miracle' or the 'Company'), a leader in vertical farming technology, today announced that the Company has entered into an equity purchase financing agreement (the 'Financing') with GHS Investments LLC ('GHS' or 'Investor'). The Company can require that the Investor invest up to Twenty Million Dollars ($20,000,000) to purchase the Company's shares of common stock, $0.0001 par value per share ('Common Stock') over the course of twenty-four (24) months immediately following the effective date of the registration statement to be filed with the Securities and Exchange Commission ('SEC') in connection with the Financing, subject to the terms and conditions specified in the agreement. The Company issued 1,503,759 shares of Common Stock to the Investor in consideration for the Financing. In addition, the Investor made a $250,000 investment in the Company's Series A shares of preferred stock (the 'Series A Shares'), which shares are convertible into shares of Common Stock at a conversion price of $0.112 per share. The Company will be filing a registration statement to register all of the foregoing securities, and will file an 8-K providing additional information about the foregoing transactions. About Nature's Miracle Holding Inc. Nature's Miracle ( ) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture ('CEA') industry in the U.S. The Company's Common Stock trades on the OTCQB market ('OTCQB') under the symbol 'NMHI'. Forward-Looking Statements The information in this press release includes 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words 'anticipate,' 'believe,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'forecast,' 'intends,' 'may,' 'will,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'would' and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature's Miracle's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature's Miracle's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature's Miracle's ability to develop and launch new products and services; Nature's Miracle's ability to successfully and efficiently integrate future expansion plans and opportunities; Nature's Miracle's ability to grow its business in a cost-effective manner; Nature's Miracle's product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature's Miracle's business model; developments and projections relating to Nature's Miracle's competitors and industry; and Nature's Miracle's approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company's shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature's Miracle's operates; the risk that Nature's Miracle's and its current and future collaborators are unable to successfully develop and commercialize Nature's Miracle's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature's Miracle's is unable to secure or protect its intellectual property; the possibility that Nature's Miracle's may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature's Miracle's filings from time to time with the SEC. View original content: SOURCE Nature's Miracle Holding Inc.
